Senior Manager, Biostatistics at Bristol-Myers Squibb

Warsaw, Masovian Voivodeship, Poland

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Fresh PhD with 3+ years’ experience or MS with 5+ years’ experience in statistics or biostatistics or related scientific field with clinical trials, drug development, pharmaceutical industry or healthcare experience
  • Proficiency in scientific computing/programming (SAS, R or Python) and implementation of advanced statistical analysis, data manipulation, graphing & simulation
  • Good interpersonal, communication, writing and organizational skills
  • Ability to learn regulatory requirements & clinical trial design, data analysis and interpretation
  • Ability to work successfully within cross-functional teams
  • Ability to organize multiple work assignments and establish priorities
  • Experience in standard and advanced statistical methods (preferred)
  • Good understanding of regulatory requirements & clinical trial design (preferred)

Responsibilities

  • Collaborates in design of clinical study including methodology, data analysis & interpretation, and reporting of study results
  • Authors and/or reviews protocol synopsis, protocol, statistical analysis plans, case-report forms, clinical study reports, associated publications, and other study level specification documents with minimum supervision
  • Performs and/or validates statistical analyses, advise ways to maximize clarity of data display
  • Communicates results to cross-functional teams, provides data interpretation in study documents such as clinical study reports, and publications
  • Translates scientific questions into statistical terms and statistical concepts into layman terms
  • Compliant with BMS processes and SOPs, adherence to global and project standards within an indication or therapeutic area and responsible for quality of deliverable
  • Continually develops technical knowledge of statistical methodology and how it is appropriately applied in trial design and data analysis for clear, concise, high-quality results
  • Continually enhances knowledge of drug development process, regulatory and commercial requirement
  • Develops & advises team members
  • Effectively communicates the GBDS Mission and Vision in a fashion that generates pride, excitement and commitment within GBDS
  • Enables a culture of inclusiveness, respect for diversity, compliance with process and allows for the questioning and challenging of others in a respectful and constructive manner

Skills

Biostatistics
Clinical Trial Design
Statistical Analysis
Protocol Development
Statistical Analysis Plans
Data Interpretation
Regulatory Submissions
SAS
R

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI